RTx is a startup company founded by Dr. Raúl J. Gazmuri M.D., Ph.D. in 2017 with the mission of developing and commercializing new therapies and strategies for resuscitation from life-threatening medical emergencies in pre-hospital and hospital settings in civilian and military environments. The company has its roots in decades of preclinical research conducted by the founder and his team at the Resuscitation Institute of Rosalind Franklin University of Medicine and Science identifying promising new therapies and strategies for resuscitation.